Kartos Therapeutics News and Activities

Acquisition, funding and merger involving Kartos Therapeutics.

• Ipsen has announced the acquisition of Kartos Therapeutics  (posted on July 3 2026).

View the org chart displaying its 19 main executives

Most searched biographies at Kartos Therapeutics

• Jesse McGreivy, Chief Executive Officer
• Flavia Borellin, Independent Board Director
• Roger Ulrich, Director

Popular executive movements at Kartos Therapeutics

• Anna Nekhymchuk who was Associate Director Clinical Operations, becomes Director Clinical Operations  (posted on July 1 2026).

Create your alert
to follow the executive moves at Kartos Therapeutics.

Kartos Therapeutics has 2,432 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Crystalys Therapeutic has just announced a $130 Million fundraising (posted on July 23 2026).
• Ipsen has acquired Memo Therapeutics (posted on July 22 2026).
• AdvanCell has just announced a $315 Million fundraising (posted on July 21 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by Kartos Therapeutics

Social media about Kartos Therapeutics

• Kartos Therapeutics on Wikipedia, Google News & Yahoo Finance
• Kartos Therapeutics on LinkedIn, X (Twitter) & YouTube